Alzheimer’s Disease Neuroimaging Initiative

4453 Total Publications

Year	Title	Author	Journal
2014	Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease	Li, R., Perneczky, R., Yakushev, I., Förster, S., Kurz, A., Drzezga, A., & Kramer, S.	Journal PloS One;
2014	An Efficient Approach for Differentiating Alzheimer’s Disease from Normal Elderly Based on Multicenter MRI Using Gray-Level Invariant Features	Li, M., Oishi, K., He, X., Qin, Y., Gao, F., & Mori, S.	Journal PloS One;
2014	Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer’s Disease	Liu, Y., Yu, J.-T., Wang, H.-F., Hao, X.-K., Yang, Y.-F., Jiang, T., … Tan, L.	Journal PloS One;
2014	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid	Kauwe JS1, Bailey MH1, Ridge PG1, Perry R1, Wadsworth ME1, Hoyt KL1, Staley LA1, Karch CM2, Harari O3, Cruchaga C2, Ainscough BJ4, Bales K5, Pickering EH5, Bertelsen S3; Alzheimer's Disease Neuroimaging Initiative, Fagan AM6, Holtzman DM7, Morris JC8, Goate AM9	Journal PLoS Genet.;
2014	Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data	Gomar, J. J., Conejero-Goldberg, C., Davies, P., & Goldberg, T. E.	Journal Alzheimer's and Dementia;
2014	Analysis of sub-anatomic diffusion tensor imaging indices in white matter regions of Alzheimer withMMSE score	Patil, R. B., & Ramakrishnan, S.	Journal Computer Methods and Programs in Biomedicine;
2014	Overrepresentation of Glutamate Signaling in Alzheimer’s Disease: Network-Based Pathway Enrichment Using Meta-Analysis of Genome-Wide Association Studies	Pérez-Palma, E., Bustos, B. I., Villamán, C. F., Alarcón, M. A., Avila, M. E., Ugarte, G. D., … De Ferrari, G. V.	Journal PloS One;
2014	Alzheimer’s disease progression model based on integrated biomarkers and clinical measures	Qiu, Y., Li, L., Zhou, T., & Lu, W.	Journal Acta Pharmacologica Sinica;
2014	SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease	Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., … Nöthen, M. M.	Journal Human Molecular Genetics;
2014	Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.	Peterson, D., Munger, C., Crowley, J., Corcoran, C., Cruchaga, C., Goate, A. M., … Kauwe, J. S. K.	Journal Alzheimer's and Dementia;